A mitochondria-targeted tetrapeptide studied for mitochondrial function research, cardiolipin-related mechanisms, oxidative stress pathways, ATP production, cellular energy metabolism, mitochondrial membrane integrity, and age-related mitochondrial dysfunction models.

Product Overview

Compound: SS-31 / Elamipretide
Strength: 50 mg per vial
Injection type: Research protocol dependent
Frequency: Research protocol dependent

Reconstitution

Amount in vial: 50 mg
BAC water: 2 mL
Amount per unit: 250 mcg per unit

Research Dose

Protocol dependent.

Notes

SS-31, also known as Elamipretide, MTP-131, or Bendavia, is described as a mitochondria-targeted tetrapeptide that selectively interacts with cardiolipin, a phospholipid found in the inner mitochondrial membrane. Cardiolipin is involved in maintaining mitochondrial structure, electron transport chain function, and cellular energy production.

Research literature has examined SS-31 for its role in mitochondrial membrane stabilization, oxidative stress modulation, ATP production, electron transport chain efficiency, mitochondrial cristae structure, and cellular energy metabolism.

Preclinical and clinical research contexts have explored SS-31 in relation to mitochondrial dysfunction, skeletal muscle performance, cardiovascular models, kidney injury models, neurodegeneration-related pathways, and age-associated mitochondrial decline.

Most available evidence comes from laboratory, animal, and clinical research contexts. No standard consumer dosing protocol should be assumed.

Use only within appropriate research or professional guidance frameworks.